47

Allied Supreme Corp

4770 · TW · Basic Materials / Specialty Chemicals

299.00TWD+9.00 (+3.10%)

Price History

Full chart

Market Stats

Previous Close290.00
Open300.00
Day Range296.50 – 313.50
52-Week Range197.86 – 301.41
Volume1.28M
Market Cap22.23B
P/E (TTM)26.60
Forward P/E0.00
EPS10.45
Dividend Yield2.16%
Beta0.78
50-Day Avg231.25
200-Day Avg231.96

About

Allied Supreme Corp., together with its subsidiaries, manufactures and sells fluoropolymer resin in China, America, and Taiwan. The company offers fluoropolymer materials, lining products, and coatings; customized products, such as injection molding products, overflow sink/tank, PTFE micro-powders, and PTFE compounds; and solutions for semiconductor, flat panel display, solar, pharmaceutical, biochemical, petrochemical, and traditional chemical industries. It also provides fluoropolymer lining, such sheet lining, iso container, immersion coil and shell and tube type heat exchanger; chemical filter housing; lined pipe and fittings; flexible hose and fluoropolymer coating. It serves the semiconductor, panel, and petrochemical industries. Allied Supreme Corp. was founded in 1981 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorBasic Materials
  • IndustrySpecialty Chemicals
  • CEOMr. Chiao-Sheng Ho
  • Employees0
  • HeadquartersNo.12, Mingzu East Road, Taipei, Taiwan, 10461, Taiwan
  • Websitehttps://www.alliedsupreme.com

Leadership

  • Mr. Chiao-Sheng HoChairman of the Board & GM
  • Ya-Fang YinFinance Officer & Corporate Governance Officer
  • Mr. Yuan-Chung LeeCOO & Director
  • Chi-Fang LinAccounting Officer
  • Mr. Yu-Ming HuangVice President
  • Yang-Mao ZhaoDeputy General Manager
  • Zhi Cheng ZhangProduct Development Manager
  • Zhen Long WangDeputy Manager of Management Department
  • Wen Rong ZhuangSales Department Assistant

Financials

Income Statement

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.30B2.38B2.59B2.63B3.83B6.14B5.69B6.46B4.73B
Growth (%)-+3.74%+8.55%+1.76%+45.72%+60.11%-7.26%+13.44%-26.81%
Cost of Revenue1.17B1.39B1.60B1.65B2.18B3.37B3.05B3.83B3.17B
Gross Profit1.13B993.02M983.27M978.60M1.66B2.77B2.64B2.63B1.56B
Gross Margin49.14%41.69%38.03%37.20%43.22%45.05%46.45%40.73%32.98%
Operating Expense319.56M308.43M351.19M351.87M464.65M638.83M628.45M647.60M555.47M
Operating Income808.55M684.59M632.08M626.74M1.19B2.13B2.02B1.98B1.00B
Operating Margin35.22%28.74%24.45%23.82%31.10%34.64%35.41%30.70%21.22%
EBITDA825.22M789.40M684.53M705.26M1.29B2.30B2.25B2.33B1.19B
EBITDA Margin35.94%33.14%26.48%26.81%33.62%37.53%39.61%36.03%25.24%
Net Income592.66M496.36M499.75M526.39M966.30M1.78B1.68B1.73B815.86M
Net Income Margin25.81%20.84%19.33%20.01%25.21%28.93%29.57%26.83%17.26%
R&D40.33M57.76M76.70M62.98M106.93M158.27M154.38M129.42M136.88M
R&D as % of Total Revenue1.76%2.42%2.97%2.39%2.79%2.58%2.71%2.00%2.90%
Interest Expense2.05M3.08M8.68M6.57M2.51M3.75M5.93M6.22M5.75M
Interest Expense % of Total Revenue0.09%0.13%0.34%0.25%0.07%0.06%0.10%0.10%0.12%

Balance Sheet

Currency: TWD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.52B2.87B3.90B4.10B4.73B8.15B9.53B9.97B10.70B10.35B
Total Liabilities937.26M850.12M1.52B1.53B1.87B2.62B2.80B2.53B2.35B2.12B
Total Equity1.58B2.02B2.36B2.57B2.86B5.54B6.73B7.44B8.35B8.23B
Cash581.09M403.55M560.33M525.23M805.25M3.72B3.37B3.36B3.53B3.23B
Total Debt264.98M50.75M594.50M808.97M987.80M601.04M434.34M514.25M435.67M482.96M
Net Debt-316.11M-352.80M34.17M283.74M182.55M-3.12B-2.93B-2.85B-3.09B-2.74B

Cash Flow

Currency: TWD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow360.99M403.92M245.00M743.94M1.48B875.43M828.56M1.47B1.60B
Investing Cash Flow-203.06M-670.03M-192.13M-376.64M107.80M-456.45M-5.62M-317.36M-964.06M
Financing Cash Flow-334.52M424.90M-83.55M-92.75M1.33B-790.76M-845.73M-1.03B-931.63M
Capital Expenditure22.20M55.95M144.53M522.13M416.52M390.85M197.13M232.37M179.29M
Free Cash Flow338.79M347.97M108.67M221.81M1.07B484.57M631.44M1.24B1.42B
Dividends Paid166.75M168.50M272.40M275.20M295.84M628.36M948.44M959.71M959.71M
FCF to OCF93.85%86.15%44.36%29.82%71.93%55.35%76.21%84.22%88.80%
Dividend Paid to FCF49.22%48.42%250.66%124.07%27.72%129.67%150.20%77.38%67.48%

Earnings

Report DateMar 14, 2022May 11, 2022Aug 11, 2022Nov 8, 2022Mar 21, 2023May 8, 2023Aug 9, 2023Nov 13, 2023Mar 14, 2024May 9, 2024Aug 9, 2024Nov 12, 2024Mar 7, 2025May 9, 2025Aug 11, 2025Nov 12, 2025Mar 15, 2026Mar 31, 2026Jun 30, 2026
EPS Estimate3.724.504.855.425.696.045.444.554.845.205.565.575.532.764.413.982.514.175.66
EPS Actual4.014.485.575.826.396.704.724.824.846.125.005.285.202.602.753.051.80--
Surprise7.80%-0.44%14.85%7.38%12.30%10.93%-13.24%5.93%0.00%17.69%-10.07%-5.21%-5.97%-5.80%-37.64%-23.37%-28.29%--
TimingAfter-hours-Pre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours--

Key Statistics & Ratios

Market Cap22.23B
Enterprise Value18.35B
Trailing P/E26.60
Forward P/E0.00
Price / Sales4.62
Price / Book2.62
EPS10.45
Book Value104.86
Revenue (TTM)4.81B
Gross Profit (TTM)1.55B
EBITDA1.12B
Profit Margin17.43%
Operating Margin22.97%
Return on Equity10.58%
Return on Assets5.93%
Shares Outstanding79.98M
Shares Float33.01M
Beta0.78
Dividend Yield2.16%
Dividend Rate6.00
Payout Ratio123.71%

Dividends

20261×
6.00Apr 1, 2026
20251×
12.00Mar 27, 2025
20241×
12.00Mar 28, 2024
20231×
12.00Mar 24, 2023
20221×
8.00Mar 31, 2022
20211×
4.30Jun 16, 2021